Bodick Neil 4
4 · Flexion Therapeutics Inc · Filed Feb 2, 2018
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2018-02-01+40,000→ 40,000 totalExercise: $22.31Exp: 2028-01-31→ Common Stock (40,000 underlying) - Award
Common Stock
2018-02-01+10,000→ 74,605 total
Holdings
- 388,683(indirect: By LLC)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The shares are held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
- [F2]Twenty-five percent (25%) of the shares subject to the option shall vest one year after January 1, 2018; thereafter one-forty-eighth (1/48th) of the shares subject to the option shall vest each month following the one year anniversary of January 1, 2018, so that all of the shares subject to the option shall be vested four (4) years after January 1, 2018.